Literature DB >> 3874256

Origin and specificity of autoreactive T cells in antigen-induced populations.

D A Faherty, D R Johnson, M Zauderer.   

Abstract

We have characterized the major histocompatibility complex (MHC) specificity of autoreactive T cell clones arising from diverse donors after immunization with different antigens. The MHC fine specificity of autoreactive T cells for unique F1 hybrid determinants of BALB.K X BALB.B F1, and for the mutant I-Ab determinants of the B6.C-H-2bm12 (bm 12) strain is similar to that previously described for antigen-specific T cells. We find, furthermore, that the MHC specificity of autoreactive T cell clones selected from primed populations grown in the absence of Con A-stimulated supernatant factors reflects the predominant MHC restriction specificity of T cells specific for the immunogen. Thus, I-E subregion-specific autoreactive T cells are detected at a much higher frequency after immunization with the I-E-restricted antigen, GL (terpolymer of glutamic acid, lysine, and phenylalanine), than with the predominantly I-A-restricted antigen, keyhole limpet hemocyanin (KLH). These experiments strongly suggest that some autoreactive T cells are derived from antigen-stimulated precursors. This result contrasts with that obtained when autoreactive T cells are selected in bulk cultures, or in the presence of exogenous T cell factors. We conclude that, under optimal conditions, most autoreactive T cells are recruited from a relatively stable pool of predominantly I-A-specific precursors. Autoreactive precursors in this pool might themselves derive from previous antigenic stimulation, or be of independent origin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874256      PMCID: PMC2187643          DOI: 10.1084/jem.161.6.1293

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin.

Authors:  J J Mond; E Seghal; J Kung; F D Finkelman
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

2.  The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease.

Authors:  L H Glimcher; A D Steinberg; S B House; I Green
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

3.  Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice.

Authors:  J B Smith; R D Pasternak
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

4.  Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

5.  Production of autoreactive I region-restricted T cell hybridomas.

Authors:  L H Glimcher; E M Shevach
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

6.  Clonal analysis of F1 hybrid helper T cells restricted to parental or F1 hybrid major histocompatibility determinants.

Authors:  J F Sproviero; M J Imperiale; M Zauderer
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

7.  Clonal analysis of F1 hybrid helper T cells. I-A subregion-encoded hybrid determinants restrict the activity of keyhole limpet hemocyanin-specific helper T cells.

Authors:  J F Sproviero; M J Imperiale; M Zauderer
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

8.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules.

Authors:  L H Glimcher; D L Longo; I Green; R H Schwartz
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes.

Authors:  M M Kuntz; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Recognition of multiple class II signals by murine T cell antigen receptors. Speculation regarding the relationships among autoreactive, antigen-specific and alloreactive T cells.

Authors:  B W Needleman
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

2.  Fetal calf serum stimulates 'autoreactive' T-cell hybridomas.

Authors:  A M Pullen; A J Munro
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

3.  Self-reactive T cells can escape clonal deletion in T-cell receptor V beta 8.1 transgenic mice.

Authors:  K Yui; S Komori; M Katsumata; R M Siegel; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Mercury-induced autoreactive anti-class II T cell line protects from experimental autoimmune encephalomyelitis by the bias of CD8+ antiergotypic cells in Lewis rats.

Authors:  M Castedo; L Pelletier; J Rossert; R Pasquier; H Villarroya; P Druet
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

5.  Functional heterogeneity of human T cell clones from atopic and non-atopic donors.

Authors:  C A Chambers; B Zimmerman; N Hozumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

6.  IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Authors:  M Zöller
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

7.  T cell proliferation induced by anti-self-I-A-specific T cell hybridomas. Evidence of a T cell network.

Authors:  D W Kennedy; C Russo; Y T Kim; M E Weksler
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

8.  Selective enrichment of major histocompatibility complex class II-specific autoreactive T cells in the thymic Thy0 subset.

Authors:  I Kariv; R R Hardy; K Hayakawa
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.